Measles Cases Surge in the U.S.
The United States has experienced an alarming rise in measles cases in 2026, with the total exceeding any year since the virus was declared eliminated in 2000. This trend could indicate a troubling future where thousands become infected annually.
On Friday, the Centers for Disease Control and Prevention reported 2,318 confirmed measles cases so far this year, surpassing last year’s record of over 2,200 cases, which also resulted in the deaths of two unvaccinated children. The number of cases in the past two years has eclipsed those from 2000 to 2024 combined.
Turning back this trend would necessitate a concerted effort to boost vaccination rates nationwide—a task experts believe is quite unlikely under Health Secretary Robert F. Kennedy Jr., who has halted funding for vaccine hesitancy research, downplayed measles risks, and pursued evidence to support claims of vaccine dangers.
A meeting of international experts scheduled for November will assess whether the U.S. has lost its elimination status for measles, a designation once hailed as a significant achievement in public health.
Jennifer Nuzzo, head of the Pandemic Center at Brown University, expressed concern: “This is just going to keep happening. It’s going to mean living in a perpetual state of vulnerability and risk until we get vaccination levels up.”
Many cases this year are linked to a major outbreak in South Carolina, which began last October in a tight-knit evangelical Slavic community, eventually infecting nearly 1,000 individuals before being declared over in April.
However, the virus isn’t contained. Utah is grappling with an outbreak that started along its border with Arizona and has led to more than 700 cases. Virginia has reported over 170 cases from a mid-May outbreak, and Pennsylvania is also experiencing an outbreak affecting more than 100 people.
In total, the CDC has identified 35 new measles outbreaks this year, with most cases occurring in unvaccinated individuals or those whose vaccination status is unclear.
Public health experts aren’t surprised by the surge; vaccination rates have been declining. During the COVID-19 pandemic, measles vaccination rates dropped and have yet to recover to the 95 percent necessary to prevent outbreaks. Although about 93 percent of kindergartners have received the measles, mumps, and rubella vaccine, this protection varies widely across communities.
Measles, known for its high contagion rate, thrives in areas with lower immunity levels. Dr. David Kimberlin from the University of Alabama notes its relentless nature: “It’s like a heat-seeking missile.”
This year, children represent more than 70 percent of measles cases, with over 80 hospitalized due to serious complications, including pneumonia and brain swelling. Unfortunately, there are no treatments for measles, although research is ongoing to find solutions.
While many infected children lacked vaccination, health departments have also documented cases in too-young infants and individuals with conditions preventing vaccination.
The economic impact has been steep. Local and state public health departments are stretched thin as they work to track exposures, initiate vaccination drives, and conduct tests. Estimates suggest that in 2025, each measles case cost the U.S. over $100,000, factoring in healthcare expenses and lost workdays.
This measles resurgence isn’t confined to the U.S.; Canada lost its elimination status last year and has reported over a thousand cases this year. In Bangladesh, more than 8,000 cases have been confirmed since March.
Experts believe the U.S. outlook hasn’t improved due to a lack of national initiatives to boost vaccination. While the Department of Health and Human Services has claimed an “aggressive outbreak response”—including funding for containment efforts—critics argue that there has been little national messaging or public awareness campaigns on vaccinations.
